KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Sales (2016 - 2025)

Evolent Health has reported Return on Sales over the past 11 years, most recently at 0.92% for Q4 2025.

  • Quarterly results put Return on Sales at 0.92% for Q4 2025, down 88.0% from a year ago — trailing twelve months through Dec 2025 was 0.28% (down 26.0% YoY), and the annual figure for FY2025 was 0.28%, changed.
  • Return on Sales for Q4 2025 was 0.92% at Evolent Health, down from 0.04% in the prior quarter.
  • Over the last five years, Return on Sales for EVH hit a ceiling of 0.01% in Q1 2021 and a floor of 0.92% in Q4 2025.
  • Median Return on Sales over the past 5 years was 0.01% (2023), compared with a mean of 0.07%.
  • Biggest five-year swings in Return on Sales: grew 3bps in 2022 and later crashed -88bps in 2025.
  • Evolent Health's Return on Sales stood at 0.04% in 2021, then soared by 99bps to 0.0% in 2022, then tumbled by -2871bps to 0.01% in 2023, then crashed by -247bps to 0.04% in 2024, then tumbled by -2494bps to 0.92% in 2025.
  • The last three reported values for Return on Sales were 0.92% (Q4 2025), 0.04% (Q3 2025), and 0.04% (Q2 2025) per Business Quant data.